In a paper published in the New England Journal of Medicine, Fletcher Lab describes how the LoaScope, a modification their Cellscope, can provide fast and effective testing for Loa loa parasites in the blood. Using the LoaScope to analyze the blood of volunteers from villages in Cameroon, doctors were able to successfully treat more than 15,000 patients with ivermectin without serious complications.
Published in Science today, a review article by Prof. Michael Yartsev on the current decline in the diversity of species used for neuroscience research. The field has converged on a few selected model organisms, but Yartsev proposes that neuroscience might be ready to diversify again, if provided the appropriate support.
Professor Michael Yartsev has been awarded one of only 18 prestigious 2017 Packard Fellowship for Science and Engineering, to pursue new research into how our brains developed the ability to acquire language.
At the heart of the UC Berkeley-UCSF Master of Translational Medicine program is a hands-on capstone project, where student teams work on developing medical technologies from idea to bedside. Learn more about three Surgical Innovations Accelerator projects at UCSF in Spring 2017.
Professors Niren Murthy and Irina Conboy are lead authors on a new study which demonstrates the delivery of CRISPR genome-editing molecules via nanoparticles rather than via viruses. They show that CRISPR components can be packaged around individual gold nanoparticles and wrapped in a protecting polymer, and that the nanoparticles deliver the CRISPR components into a wide variety of cells efficiently.
Prof Irina Conboy’s lab has pioneered a method that paves the way to characterization of proteome alterations in vivo, whether imposed by age or disease.This research was published in Nature Communications.
Professor Amy Herr’s lab has been awarded an R33 grant as part of the 2017 Beau Biden Cancer Moonshot Initiative. The grant will fund their work on “Advanced Cancer Classification via Single-Cell Electrophoretic Cytopathology.”
The National Cancer Moonshot works to accelerate research efforts by enhancing data access and facilitating collaborations among researchers, doctors, philanthropies, patients, patient advocates, and biotechnology and pharmaceutical companies. The initiative aims to bring about a decade’s worth of advances in five years.
Bioengineering tops the new Forbes’ Best And Worst Master’s Degrees For Jobs In 2017 list! PayScale’s analysis shows that, among those with biomedical engineering master’s degrees, compensation leaps from $70,200 at the early-career stage to $129,300 by mid-career. These graduates also go on to derive high satisfaction and meaning from their jobs.
MTM alumnus Michael Hemati, Senior R&D Engineer at Theranova, has been named one of Medtech’s Rising Stars of 2017. Hematic is currently heading medical device startups Leo Labs and TruKinetics, and was one of the founders of SmartDerm, a startup founded from an MTM project.